2005/05/04 by Michael T. Osterholm · 2 citations
Medicine · Nursing · #Influenza Virus Research Studies #Pandemic #Medicine #Vaccination #Public health #Virology #Coronavirus disease 2019 (COVID-19) #2019-20 coronavirus outbreak #Influenza pandemic #Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) #Influenza A virus subtype H5N1 #Live attenuated influenza vaccine #Pandemic influenza #Influenza vaccine #Environmental health #Virus #Outbreak #Nursing #Infectious disease (medical specialty)
paper · doi:10.1056/nejmp058068
openalex publication_date 2005/05/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28
The fragile and limited production capacity of our 1950s egg-based technology for producing influenza vaccine and the lack of a national commitment to universal annual influenza vaccination mean that influenza epidemics will continue to present a substantial public health challenge. Dr. Michael Osterholm asks, So how can we prepare?